Healthcare Global Enterprises Ltd. NSE: HCG | BSE: 539787

Momentum Trap

Download real time

692.70 1.95 (0.28%)

New 52W High in past week

52,260

NSE+BSE Volume

NSE 08 Sep, 2025 2:40 PM (IST)

Healthcare Global Enterprises Ltd. share price target

Healthcare Global Enterprises Ltd. has an average share price target of 646. The consensus estimate represents a downside of -6.74% from the last price of 692.70. View 13 reports from 5 analysts offering long-term price targets for Healthcare Global Enterprises Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	08 Sep 2025	Healthcare Global	Consensus Share Price Target	692.70	692.71	-	0.00	buy	pdf Detailed Estimates
	11 Aug 2022	Healthcare Global	ICICI Securities Limited Reco Target	692.70	339.00	284.20 (143.74%)	Target met	Buy	pdf post cache		Broker Report Sequential improvement continues ICICI Securities Limited HealthCare Global Enterprises’ (HCG) Q1FY23 performance was ahead of our estimates. pdf Copy Link Share on Share on Share on Share on Alert
	30 May 2022	Healthcare Global	Prabhudas Lilladhar	692.70	347.00	280.85 (146.64%)		Buy	pdf post cache		Broker Report HEALTHCARE GLOBAL EN Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	27 May 2022	Healthcare Global	Axis Direct	692.70	330.00	276.00 (150.98%)		Buy	pdf post cache		Broker Report Result Update:Health.Global Axis Direct We recommend BUY with a target price of Rs 330. pdf Copy Link Share on Share on Share on Share on Alert
	28 Mar 2022	Healthcare Global	Axis Direct	692.70	330.00	267.70 (158.76%)		Buy	pdf post cache		Broker Report Pick of the Week:28 MAR 2022 Axis Direct We recommend BUY with a TP of Rs 330/share. pdf Copy Link Share on Share on Share on Share on Alert
	14 Mar 2022	Healthcare Global	Geojit BNP Paribas Target	692.70	294.00	254.65 (172.02%)	Target met	Accumulate	pdf post cache		Broker Report HEALTHCARE GLOBAL ENTERPRISES LIMITED Geojit BNP Paribas Healthcare Global Enterprises Ltd is one of India's leading oncology treatment specialists with presence across the country. HCG reported robust revenues in Q3FY22 growing by 31% YoY to Rs.358 cr during the quarter with secular growth across regions and... pdf Copy Link Share on Share on Share on Share on Alert
	11 Feb 2022	Healthcare Global	Axis Direct Target	692.70	330.00	242.50 (185.65%)		Buy	pdf post cache		Broker Report Result Update:Health.Global Axis Direct We recommend BUY with a target price of Rs 330. pdf Copy Link Share on Share on Share on Share on Alert
	03 Jan 2022	Healthcare Global	Axis Direct Target	692.70	267.00	245.05 (182.68%)	Target met	Buy	pdf post cache		Broker Report Pick of the Week:03 JAN 2022 Axis Direct We recommend a BUY on Healthcare Global Enterprises Ltd with a Target Price of Rs 267, an upside of 10% from CMP of Rs 243 and Stop Loss Rs 230. pdf Copy Link Share on Share on Share on Share on Alert
	08 Dec 2021	Healthcare Global	ICICI Securities Limited Target	692.70	255.00	254.55 (172.13%)	Target met	Accumulate	pdf post cache		Broker Report Management meet highlights ICICI Securities Limited We met HealthCare Global Enterprises’ (HCG) management – Dr. Ajai Kumar (Executive Chairman) and Ms. Anjali Ajaikumar Rossi (Executive Director) – to understand the company’s strategy, future prospects and industry drivers. pdf Copy Link Share on Share on Share on Share on Alert
	29 Nov 2021	Healthcare Global	Axis Direct	692.70	330.00	252.95 (173.85%)		Buy	pdf post cache		Broker Report Initiating Coverage:Health.Global Axis Direct We initiate coverage on HealthCare Global Enterprises Ltd (HCG) with a BUY rating and a target price of Rs 330 (EV/EBITDA 15x for FY24E EBITDA), implying an upside potential of 32% from the current levels. pdf Copy Link Share on Share on Share on Share on Alert
	30 Aug 2021	Healthcare Global	Geojit BNP Paribas Target	692.70	266.00	236.80 (192.53%)	Target met	Accumulate	pdf post cache		Broker Report HEALTHCARE GLOBAL ENTERPRISES LIMITED Geojit BNP Paribas Healthcare Global Enterprises Ltd is one of India's leading oncology treatment specialists with presence across the country. HCG revenues in Q1FY22 grew by 68% YoY to Rs.323cr during the quarter supported by new centres reporting a revenue growth of 124% YoY and reduced losses with several centres achieving operating EBITDA breakeven at unit level. EBITDA continued its growth trajectory to Rs.51cr (180% YoY, 30% QoQ) while weathering the second wave of the pandemic. Resultantly... pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners